FDA 510(k)
FDA class 1
Substantially Equivalent
🇺🇸 United States
COXSACKIE A2 CF ANTIGEN, A4, A10 & A16
K Number: K853279
·
Decision Nov 7, 1985
Classifications
1
FEI Numbers
0
Registration Numbers
0
Same Product Code
0
Applicant Total
33
Review Days
94
Basic Information
- Device Name
- COXSACKIE A2 CF ANTIGEN, A4, A10 & A16
- K Number
- K853279
- Device Class
- FDA class 1
- Clearance Type
- Traditional
- Regulation Number
- 866.3145
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Applicant
- HILLCREST BIOLOGICALS
- Date Received
- August 5, 1985
- Decision Date
- November 7, 1985
- Product Code
- GNO
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| GNO | Antisera, Cf, Coxsackievirus A 1-24, B 1-6 | FDA class 1 | Microbiology |
Other Clearances by HILLCREST BIOLOGICALS
| K Number | Device Name | ||
|---|---|---|---|
| K913617 | ARBOVIRUS IGG IFA TEST | Dec 3, 1992 | Substantially Equivalent |
| K913618 | ARBOVIRUS IGM IFA TEST | Dec 3, 1992 | Substantially Equivalent |
| K922374 | Q FEVER IGM IFA TEST | Oct 21, 1992 | Substantially Equivalent |
| K913906 | Q FEVER IGG IFA TEST | Oct 21, 1992 | Substantially Equivalent |
| K900206 | LYME DISEASE IGM ELISA | Jun 28, 1991 | Substantially Equivalent |
| K896594 | EBV VCA ANTIBODY (IGM) | Jan 16, 1990 | Substantially Equivalent |
| K884829 | EBV EARLY ANTIGEN (R+D) | Apr 12, 1989 | Substantially Equivalent |
| K883767 | LYME DISEASE IFA (IGM) | Mar 15, 1989 | Substantially Equivalent |
| K884591 | EBV-VCA ANTIBODY (IGG) | Jan 24, 1989 | Substantially Equivalent |
| K883487 | LYME DISEASE IFA (IGG) | Dec 13, 1988 | Substantially Equivalent |